Back

2017-06-13

SPDBI is a strategic investor of Wuxi AppTec (“WXAT”). WXAT spinned off its biological subsidiary for a HK listing
WuXi Biologics, which is an open-access biologics technology platform offering end-to-end solutions to pharmaceutical manufacturing, was listed on June 13, 2017 on the Main Board of Hong Kong Stock Exchange. The public offering was 36.5 times oversubscribed and the stock price surged 37% on the first trading day.